W. Andrew Krusen Elected to Exactech Board of Directors
May 15 2014 - 8:21AM
Business Wire
Dr. Bill Petty and Richard Smith Re-elected to
Three Year Terms
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, announced today that W. Andrew Krusen was
elected to the Board of Directors at the company’s annual meeting
of shareholders. In addition, Dr. Bill Petty and Richard Smith were
re-elected to serve three year terms on the board.
Krusen, 65, has been chairman and CEO of Dominion Financial
Group, Inc. a merchant banking organization that provides
investment capital to the natural resources, communications and
manufacturing and distribution sectors since 1987, He has also been
the managing member of Gulf Standard Energy, LLC, an oil and gas
concern, since June 2004; and the managing member of
Krusen-Douglas, LLC, a large landowner in the Tampa, Florida area,
since January 2001. He serves as a director of several publicly
traded and privately held companies, including Canada Fluorspar
Inc., Raymond James Trust Company, Florida Capital Group, Beall’s
Inc. and Romark Laboratories, L.C.
"Through product innovation, clear-thinking leadership and
outstanding core values, Exactech has positioned itself to have a
significant impact on the quality of life for so many people around
the world,” Krusen said. “I'm honored to be a part of that
mission."
Dr. Bill Petty, 71, executive chairman of Exactech, is a founder
of the company. He was chairman of the board and CEO of the company
from its inception and was president from January 2002 until
December 2007. A professor at the University of Florida College of
Medicine from July 1975 to September 1998, he also served as
chairman of the Department of Orthopaedic Surgery at the University
of Florida College of Medicine from July 1981 to January 1996.
Richard C. Smith has been a director since May 2010. He has
been a partner in Norton, Rose, Fullbright LLP's Washington DC
office, where he focuses on litigation, white-collar crime,
governmental investigation and corporate governance matters since
June 2007. He is also chair of Global White Collar Crime and
Investigations Group and co-chair of the firm's Subprime and Credit
Crisis practice group.
About Exactech
Exactech develops and markets orthopaedic implant devices,
related surgical instruments and biologic materials and services to
hospitals and physicians. The company manufactures many of its
orthopaedic devices at its Gainesville facility. Exactech’s
orthopaedic products are used in the restoration of bones and
joints that have deteriorated as a result of injury or diseases
such as arthritis. Exactech markets its products in the United
States, in addition to more than 30 markets in Europe, Latin
America, Asia and the Pacific. Additional information about
Exactech, Inc. can be found at http://www.exac.com. Copies of
Exactech’s press releases, SEC filings, current price quotes and
other valuable information for investors may be found at
http://www.exac.com and http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.com
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Sep 2023 to Sep 2024